期刊文献+

Cripto-1蛋白在急性白血病中的表达 被引量:1

原文传递
导出
摘要 Cripto-1是表皮生长因子-Cripto-FRL-Criptic(EGF-CFC)家族成员之一,其基因定位在人染色体3P21.3。已经发现Cripto-1在人类的多种肿瘤如结肠癌、乳腺癌、卵巢癌、胰腺癌等中高表达,它可以激活P13K/Akt/GSK-3βc-Src和ras/raf/MAPK信号通路,介导细胞增殖和抑制细胞凋亡。目前有关Cripto-1在急性白血病中的表达情况及其与P13K/Akt信号通路之间的关系尚未见报道,我们观察了Cripto-1和p-Akt在白血病中的表达,并分析其与临床疗效之间的关系,旨在探讨Cripto-1在白血病发生、发展及其与临床耐药的关系。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2008年第11期776-777,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献14

  • 1Saccone S, Rapisarda A, Motta S, et al. Regional localization of the human EGF-like growth facter CRIPTO gene (TDGF-1) to chromosone 3p21. Hum Genet, 1995,95:229-230.
  • 2Ciardiello F, Kim N, Saeki T, et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A, 1991,88:7792-7796.
  • 3Qi CF, Liscia DS, Normanno N, et al. Expression of transforming growth factor α, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer,1994,69:903-910.
  • 4Friess H,Yamanaka Y, Buchler M,et al. Cripto,a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer, 1994,56 : 668- 674.
  • 5D'Antonio A, Losito S, Pignata S,et al. Transforming growth factor α, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas. Int J Oncol, 2002, 21 : 941- 918.
  • 6Bianco C,Strizzi L, Rehman A, et al. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src. Cancer Res,2003,63 : 1192-1197.
  • 7Kannan S, De Santis M, Lohmeyer M,et al. Cripto enhances the tyrosine phosphorylation of Shc and activates mitogenactivated protein kinase (MAPK) in mammary epithelial cells. J Biol Chem, 1997, 272 : 3330-3335.
  • 8Ebert AD, Wechselberger C, Frank S, et al. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells. Cancer Res, 1999, 59: 4502-4505.
  • 9HiddemanW, Buchner T. Treatment strategies in acute myeloid leukemia (AML). B Second line treatmeat. Blur, 1990, 60: 163-171.
  • 10Bianco C, Strizzi L, Ebert A, el al. Role of human cripto-1 in tumor angiogenesis. J Natl Cancer Inst, 2005, 97 : 132-141.

同被引文献23

  • 1窦爱霞,贾培敏,朱琦,赵倩,王振义,童建华.腺苷酸环化酶的活化影响NB4细胞对全反式维甲酸的敏感性[J].中华血液学杂志,2004,25(11):675-678. 被引量:5
  • 2付劲蓉,刘文励,周剑锋,孙汉英,郑邈,黄梅,李春蕊,冉丹,罗莉.Mcl-1基因在HL-60细胞对全反式维甲酸耐药机制中的作用[J].中华血液学杂志,2005,26(6):352-354. 被引量:7
  • 3Awwad RT, Do K, Stevenson H, et al. Overexpression of BP1, a homeobox gene ,is associated with resistance to all-trans retinoie acid in acute promyelocytic leukemia cells [J]. Ann Hematol, 2008,87 ( 3 ) : 195 - 203.
  • 4Lulli V, Romania P, Riccioni R, et al. Transcriptional silencing of ETS1 oncogenc contributes to human granulocytic differentiation [ J ]. Haematologica,2010,95 (10) : 1633 - 1641.
  • 5Heuser M, Argiropoulos B, Kuchenbauer F,et al. MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML[J]. Blood,2007,110(5) :1639 - 1647.
  • 6Ritter M, Kattmann D, Teichler S, et al. Inhibition of retinoic acid receptor signaling by Ski in acute myeloid leukemia[J]. Leukemia,2006 ,20 (3) :437 -443.
  • 7Bianco C, Strizzi L, Rehman A, et al. A Nodal - and ALK4 - independent signaling pathway activated by Cripto - 1 through Glypiean - 1 and c - Src[J]. Cancer Res,2003,63 (6) :1192 - 1197.
  • 8Meyer PN, Roychowdhury S, Kini AR, et al. HSP90 inhibitor 17AAG causes apoptosis in ATRA - resistant acute promyelocytic leukemia cells [ J ]. Leuk Res,2008,32 ( 1 ) :143 - 149.
  • 9Miranda MB,Redner RL,Johnson DE. Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiation[J]. Mol Cancer Ther,2007,6( 12 Pt1 ) :3081 -3090.
  • 10McNamara S, Wang H, Hanna N, et al. Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function:A novel mechanism of retinoic acid resistance [ J ]. Mol Cell Biol, 2008,28 ( 6 ) : 2066 - 2077.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部